These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 13860046)

  • 1. The chronic toxicity of N-methylpyridinium-2-aldoxime methane sulphonate (P2S), a reactivator of phosphorylate cholinesterase.
    ALBANUS L; JARPLID B; SUNDWALL A
    Acta Pharmacol Toxicol (Copenh); 1961; 18():321-8. PubMed ID: 13860046
    [No Abstract]   [Full Text] [Related]  

  • 2. Minimum concentrations of N-methylpyridinium-2-aldoxime methane sulphonate (P2S) which reverse neuromuscular block.
    SUNDWALL A
    Biochem Pharmacol; 1961 Dec; 8():413-7. PubMed ID: 13918436
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro reactivation and "ageing" of Tabuninhibited blood cholinesterases; studies with N-methyl-pyridinium-2-aldoxime methane sulphonate and N,N'-trimethylene bis (pyridinium-4-aldoxime) dibromide.
    HEILBRONN E
    Biochem Pharmacol; 1963 Jan; 12():25-36. PubMed ID: 13953372
    [No Abstract]   [Full Text] [Related]  

  • 4. Reactivation of phosphorylated acetocholinesterases by pyridinium aldoximes and related compounds.
    HOBBIGER F; PITMAN M; SADLER PW
    Biochem J; 1960 May; 75(2):363-72. PubMed ID: 14402133
    [No Abstract]   [Full Text] [Related]  

  • 5. The toxicity of 2-hydroxyiminomethyl-N-methylpyridinium methanesulphonate (P2S).
    DAVIES DR; WILLEY GL
    Br J Pharmacol Chemother; 1958 Jun; 13(2):202-6. PubMed ID: 13536287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic studies on N-methylpyridinium-2-aldoxime. III. Experiments with the 14C-labelled compound.
    ENANDER I; SUNDWALL A; SORBO B
    Biochem Pharmacol; 1962; 11():377-82. PubMed ID: 13890155
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic studies on N-methylpyridinium-2-aldoxime. I. The conversion to thiocyanate.
    ENANDER I; SUNDWALL A; SORBO B
    Biochem Pharmacol; 1961 Aug; 7():226-31. PubMed ID: 13696730
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the renal elimination of N-methylpyridinium-2-aldoxime.
    BERGLUND F; ELWIN CE; SUNDWALL A
    Biochem Pharmacol; 1962; 11():383-8. PubMed ID: 13867725
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolic studies on N-methylpridinium-2-aldoxime. II. The conversion to N-methylpyridinium-2-nitrile.
    ENANDER I; SUNDWALL A; SORBO B
    Biochem Pharmacol; 1961 Aug; 7():232-6. PubMed ID: 13696729
    [No Abstract]   [Full Text] [Related]  

  • 10. CHRONIC INTRAVENOUS TOXICITY OF THE OXIMES OF 2-FORMYL-1-METHYLPYRIDINIUM CHLORIDE AND THE METHANESULFONATE ANALOG TO DOGS AND RABBITS.
    CROOK JW; CRESTHULL P; O'NEIL HW; OBERST FW
    Toxicol Appl Pharmacol; 1964 May; 6():310-5. PubMed ID: 14194762
    [No Abstract]   [Full Text] [Related]  

  • 11. [2 cases of poisoning by phosphoric esters treated by a cholinesterase reactivator (pyridine-2-aldoxime methyl methanesulfonate)].
    LEVEQUE J; TROTEMANN S; DELONS S
    Maroc Med; 1961 Apr; 40():405-12. PubMed ID: 13761358
    [No Abstract]   [Full Text] [Related]  

  • 12. [Certain observations on the toxicity of pyridine-2-aldoxime methiodide (PAM-2)].
    BARYLA K; BINENFELD Z; BOZIC V; STEVANOVIC M; VOJVODIC V
    Vojnosanit Pregl; 1959; 16():594-7. PubMed ID: 13797348
    [No Abstract]   [Full Text] [Related]  

  • 13. Protection against lethal organophosphate poisoning by quaternary pyridine aldoximes.
    HOBBIGER F; SADLER PW
    Br J Pharmacol Chemother; 1959 Jun; 14(2):192-201. PubMed ID: 13662573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Hydroxyiminomethyl-N-methylpyridinium methanesulphonate (P2S), an antidote to organophosphorus poisoning. Its preparation, estimation and stability.
    CREASEY NH; GREEN AL
    J Pharm Pharmacol; 1959 Aug; 11():485-90. PubMed ID: 13812738
    [No Abstract]   [Full Text] [Related]  

  • 15. Oximes of alpha omega-diquaternary alkane salts as antidotes to organophosphate anticholinesterases.
    BERRY WK; DAVIES DR; GREEN AL
    Br J Pharmacol Chemother; 1959 Jun; 14(2):186-91. PubMed ID: 13662572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjunctive value of oral prophylaxis with the oximes 2-PAM lactate and 2-PAM methanesulfonate to therapeutic administration of atropine in dogs poisoned by inhaled Sarin vapor.
    CROOK JW; GOODMAN AI; COLBOURN JL; ZVIRBLIS P; OBERST FW; WILLS JH
    J Pharmacol Exp Ther; 1962 Jun; 136():397-9. PubMed ID: 13882343
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro studies on the reactivation by oximes of phosphylated acetylcholinesterase--I. On the reactions of P2S with various organophosphates and the properties of the resultant phosphylated oximes.
    Harvey B; Scott RP; Sellers DJ; Watts P
    Biochem Pharmacol; 1986 Mar; 35(5):737-44. PubMed ID: 3954783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of methyl pyridinium-2-aldoxime salts.
    KONDRITZER AA; ELLIN RI; EDBERG LJ
    J Pharm Sci; 1961 Feb; 50():109-12. PubMed ID: 13752933
    [No Abstract]   [Full Text] [Related]  

  • 19. 2-Hydroxyiminomethyl-N-methylpyridinium methanesulphonate and atropine in the treatment of severe organophosphate poisoning.
    DAVIES DR; GREEN AL; WILLEY GL
    Br J Pharmacol Chemother; 1959 Mar; 14(1):5-8. PubMed ID: 13651571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of some oximes in sarin poisoning.
    RUTLAND JP
    Br J Pharmacol Chemother; 1958 Dec; 13(4):399-403. PubMed ID: 13618543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.